Amneal Pharmaceuticals, Inc.

NYSE:AMRX

8.71 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015
Assets:
Current Assets:
Cash & Cash Equivalents 91.54225.976247.79341.378151.197213.39474.16627.36761.087
Short Term Investments 01.8211.1741.6961.1232.1421.8514.3544.977
Cash and Short Term Investments 91.54225.976247.79341.378151.197213.39474.16631.72166.064
Net Receivables 645.66742.291663.762640.302606.157482.325382.727394.786273.832
Inventory 581.384530.735489.389490.649381.067457.219284.038266.161234.965
Other Current Assets 91.205103.565110.21873.46770.164128.32131.00233.44629.741
Total Current Assets 1,377.8631,411.8181,520.1081,551.5391,210.211,286.644771.933726.114604.602
Non-Current Assets:
Property, Plant & Equipment, Net 550.137589.36639.003595.169609.153544.146486.758407.404318.822
Goodwill 598.629598.853593.017522.814419.504426.22626.44428.44129.824
Intangible Assets 890.4231,096.0931,166.9221,304.6261,382.7531,654.96944.59945.92949.691
Goodwill and Intangible Assets 1,489.0521,694.9461,759.9391,827.441,802.2572,081.19571.04374.3779.515
Long Term Investments 085.5860016.3730000
Tax Assets 0-85.58600-16.373373.1590.89800
Other Non-Current Assets 55.517103.21720.61431.88544.2767.59211.257-481.774-398.337
Total Non-Current Assets 2,094.7062,387.5232,419.5562,454.4942,455.683,066.092569.956481.774398.337
Total Assets 3,472.5693,799.3413,939.6644,006.0333,665.894,352.7361,341.8891,218.8171,014.093
Liabilities & Equity:
Current Liabilities:
Account Payables 143.572538.199583.345613.661507.483514.4470.01360.03369.929
Short Term Debt 227.624104.63946.03755.6836.95421.71589.48200
Tax Payables 00.3592.5235.5388.7290000
Deferred Revenue 398.411000017.429137.07700
Other Current Liabilities 76.988109.96247.8617.5615.9690.2660.311165.04169.219
Total Current Liabilities 846.595752.8677.243676.902550.406553.85296.883225.073239.148
Non-Current Liabilities:
Long Term Debt 2,522.8992,740.4962,830.0192,885.1282,729.1132,669.6811,395.2611,159.566951.621
Deferred Revenue Non-Current 00000015.04300
Deferred Tax Liabilities Non-Current 000001.1782.49100
Other Non-Current Liabilities 83.06497.11765.42999.07139.583231.6647.793-1,159.566-951.621
Total Non-Current Liabilities 2,605.9632,837.6132,895.4482,984.1992,768.6962,902.5231,420.5881,159.566951.621
Total Liabilities 3,452.5583,590.4133,572.6913,661.1013,319.1023,456.3731,717.4711,394.7621,200.966
Equity:
Preferred Stock 00000391.613380.06900
Common Stock 3.0663.0363.0142.9972.9922.9872.7162.6752.675
Retained Earnings -490.176-406.183-276.197-286.821-377.88-20.92-382.785-175.168-181.974
Accumulated Other Comprehensive Income/Loss -32.3499.939-24.827-41.318-0.068-7.755-14.23200
Other Total Stockholders Equity 539.24577.187664.983670.074721.744530.438-371.507-12.797-15.844
Total Shareholders Equity 19.781183.979366.973344.932346.788896.363-385.739-185.29-195.143
Total Equity 20.011208.928373.606386.593461.5661,287.976-375.582-175.945-186.873
Total Liabilities & Shareholders Equity 3,472.5693,799.3413,939.6644,006.0333,665.894,352.7361,341.88900